Kato, Y.; Kawaguchi, H.; Sakata, N.; Ueda, S.; Okano, M.; Nishino, Y.; Ryujin, M.; Takemura, Y.; Takemura, T.; Sugimoto, K.;
et al. Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. Children 2023, 10, 871.
https://doi.org/10.3390/children10050871
AMA Style
Kato Y, Kawaguchi H, Sakata N, Ueda S, Okano M, Nishino Y, Ryujin M, Takemura Y, Takemura T, Sugimoto K,
et al. Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. Children. 2023; 10(5):871.
https://doi.org/10.3390/children10050871
Chicago/Turabian Style
Kato, Yutaka, Hiroshi Kawaguchi, Naoki Sakata, Satoshi Ueda, Munehiro Okano, Yuuki Nishino, Masako Ryujin, Yutaka Takemura, Tsukasa Takemura, Keisuke Sugimoto,
and et al. 2023. "Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report" Children 10, no. 5: 871.
https://doi.org/10.3390/children10050871
APA Style
Kato, Y., Kawaguchi, H., Sakata, N., Ueda, S., Okano, M., Nishino, Y., Ryujin, M., Takemura, Y., Takemura, T., Sugimoto, K., & Okada, S.
(2023). Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report. Children, 10(5), 871.
https://doi.org/10.3390/children10050871
